Clinical Trial Update: Efficacy and Safety of Intra-arterial Tenecteplase in Acute Ischemic Stroke Patients With Medium Vessel Occlusion Stroke (DATE-MeVO) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (DATE-MeVO) is evaluating the efficacy and safety of intra-arterial tenecteplase for acute ischemic stroke due to medium vessel occlusi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Tenecteplase (tenecteplase)

Snippet

Sponsor: Southwest Hospital, China | Conditions: Acute Ischemic Stroke | Phase 3 | Status: NOT_YET_RECRUITING